Direct and Indirect Costs Associated to Type 2 Diabetes and Its Complications Measured in a Social Security Institution of Argentina

Overview

Journal Int J Public Health

Specialty Public Health

Date 2014 Sep 6

PMID 25189732

Citations 10

Authors

Jorge F Elgart

Santiago Asteazaran

Jorge L De La Fuente

Cecilia Camillucci

Jonathan B Brown

Juan Jose Gagliardino

Affiliations

Soon will be listed here.

Abstract

Objectives: To estimate direct and indirect costs of care of type 2 diabetes (T2DM) and its complications in Argentina, and compare them with those recorded in people without diabetes (ND).

Methods: Observational retrospective case-control study performed in one institution of the Social Security System of Argentina. Participants were identified and randomly selected from the Institution's electronic medical records. We recruited persons with T2DM with (387) or without (387) chronic complications and 774 ND, matched by age and gender. Data were obtained by telephone interviews and supplemented with data from the Institution's records. Parametric and non-parametric tests were used for group comparisons.

Results: Direct costs were higher in people with T2DM than in ND: twice as high in people with T2DM without complications and 3.6 times in those with complications. Absenteeism was only higher in T2DM with complications, but there were no differences among groups either in the duration or in the cost of such absenteeism.

Conclusions: T2DM and the development of its complications are positively associated with higher direct costs in Argentina.

Citing Articles

A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries.

Butt M, Ong S, Rafiq A, Kalam M, Sajjad A, Abdullah M J Pharm Policy Pract. 2024; 17(1):2322107.

PMID: 38650677 PMC: 11034455. DOI: 10.1080/20523211.2024.2322107.

Arterial Stiffness: Its Relation with Prediabetes and Metabolic Syndrome and Possible Pathogenesis.

Gagliardino J, Salazar M, Espeche W, Tolosa Chapasian P, Gomez Garizoain D, Olano R J Clin Med. 2021; 10(15).

PMID: 34362033 PMC: 8348675. DOI: 10.3390/jcm10153251.

Health Literacy in the Population of Diabetic Patients in Iran: A Systematic Review and Meta-Analysis.

Momeni M, Mirmohammadkhani M, Ziari A Iran J Public Health. 2020; 49(4):617-627.

PMID: 32548041 PMC: 7283175.

The costs of diabetes treatment in low- and middle-income countries: a systematic review.

Moucheraud C, Lenz C, Latkovic M, Wirtz V BMJ Glob Health. 2019; 4(1):e001258.

PMID: 30899566 PMC: 6407562. DOI: 10.1136/bmjgh-2018-001258.

Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomes.

Gagliardino J, Arechavaleta R, Eliaschewitz F, Iglay K, Brodovicz K, Gonzalez C J Clin Transl Endocrinol. 2019; 15:76-80.

PMID: 30788219 PMC: 6369257. DOI: 10.1016/j.jcte.2019.01.002.

References

Zhuo X, Zhang P, Hoerger T . Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med. 2013; 45(3):253-61. DOI: 10.1016/j.amepre.2013.04.017. View

Williams R, Van Gaal L, Lucioni C . Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002; 45(7):S13-7. DOI: 10.1007/s00125-002-0859-9. View

Arredondo A, Reyes G . Health disparities from economic burden of diabetes in middle-income countries: evidence from México. PLoS One. 2013; 8(7):e68443. PMC: 3709919. DOI: 10.1371/journal.pone.0068443. View

Le C, Lin L, Jun D, Jianhui H, Keying Z, Wenlong C . The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiol. 2011; 165(2):273-7. DOI: 10.1016/j.ijcard.2011.08.039. View

Lesniowska J, Schubert A, Wojna M, Skrzekowska-Baran I, Fedyna M . Costs of diabetes and its complications in Poland. Eur J Health Econ. 2013; 15(6):653-60. PMC: 4059958. DOI: 10.1007/s10198-013-0513-0. View

. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013; 36(4):1033-46. PMC: 3609540. DOI: 10.2337/dc12-2625. View

Gagliardino J, Lapertosa S, Pfirter G, Villagra M, Caporale J, Gonzalez C . Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR). Diabet Med. 2013; 30(9):1102-11. DOI: 10.1111/dme.12230. View

Alexander G, Sehgal N, Moloney R, Stafford R . National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med. 2008; 168(19):2088-94. PMC: 2868588. DOI: 10.1001/archinte.168.19.2088. View

Alhowaish A . Economic costs of diabetes in Saudi Arabia. J Family Community Med. 2013; 20(1):1-7. PMC: 3663158. DOI: 10.4103/2230-8229.108174. View

10.

Bertoldi A, Kanavos P, Franca G, Carraro A, Tejada C, Hallal P . Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health. 2013; 9:62. PMC: 4220809. DOI: 10.1186/1744-8603-9-62. View

11.

Caporale J, Elgart J, Gagliardino J . Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy. Global Health. 2013; 9:54. PMC: 3826662. DOI: 10.1186/1744-8603-9-54. View

12.

Tunceli K, Bradley C, Nerenz D, Williams L, Pladevall M, Lafata J . The impact of diabetes on employment and work productivity. Diabetes Care. 2005; 28(11):2662-7. DOI: 10.2337/diacare.28.11.2662. View

13.

Trento M, Gamba S, Gentile L, Grassi G, Miselli V, Morone G . Rethink Organization to iMprove Education and Outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care. 2010; 33(4):745-7. PMC: 2845019. DOI: 10.2337/dc09-2024. View

14.

. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

15.

Jonsson B . Revealing the cost of Type II diabetes in Europe. Diabetologia. 2002; 45(7):S5-12. DOI: 10.1007/s00125-002-0858-x. View

16.

Gagliardino J, Etchegoyen G . A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care. 2001; 24(6):1001-7. DOI: 10.2337/diacare.24.6.1001. View

17.

Bahia L, Araujo D, Schaan B, Dib S, Negrato C, Leao M . The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health. 2011; 14(5 Suppl 1):S137-40. DOI: 10.1016/j.jval.2011.05.009. View

18.

Hex N, Bartlett C, Wright D, Taylor M, Varley D . Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012; 29(7):855-62. DOI: 10.1111/j.1464-5491.2012.03698.x. View

19.

Elgart J, Caporale J, Asteazaran S, De La Fuente J, Camilluci C, Brown J . Association between socioeconomic status, type 2 diabetes and its chronic complications in Argentina. Diabetes Res Clin Pract. 2014; 104(2):241-7. DOI: 10.1016/j.diabres.2014.02.010. View

20.

Rice D . Estimating the cost of illness. Am J Public Health Nations Health. 1967; 57(3):424-40. PMC: 1227175. DOI: 10.2105/ajph.57.3.424. View